🔎 Trials Near Me

Home › Autism › NCT07084324

Spanish-language Executive Function Intervention for Children With Autism and/or ADHD

Recruiting

Evaluating a Spanish-language Executive Functioning Intervention for Children With Autism and/or ADHD and Their Families

Who can join

Ages 8 to 11 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Child is 8-11 years old.
* Child meets DSM-5 criteria for Autism Spectrum Disorder and/or ADHD
* Child has verbal skills at a 7-year-old level or greater (as measured by WASI Vocabulary and Similarities subtests)
* Caregiver endorses at least one of the following executive functioning problems:
* Difficulty accepting feedback or criticism.
* Difficulty handling frustration.
* Difficulty starting non-preferred activities.
* Frequent meltdowns.
* Not stopping a behavior after being told to stop.
* Shutting down in the face of a challenge.
* Caregiver is at least 18 years old.
* Caregiver identifies Spanish as their preferred or primary language.

Exclusion Criteria:

\- Individuals will be excluded only if they do not meet one or more of the inclusion criteria listed above.

About the study

The goal of this clinical trial is to learn whether the Spanish-language version of Unstuck and On Target (SL-Unstuck), an executive functioning (EF) intervention, is feasible, acceptable, and effective for Spanish-speaking caregivers and their neurodivergent children (ages 8-11) in the U.S.. The main questions it aims to answer are:

* Is SL-Unstuck acceptable to Spanish-speaking caregivers and children? * Does SL-Unstuck improve child EF, caregiver EF knowledge, and caregiver strain?

Researchers will compare families randomly assigned to immediate SL-Unstuck versus waitlist control to see if participating in the intervention improves EF and family outcomes.

Participants will:

* Attend 8 weekly SL-Unstuck sessions at a clinic (parallel child and caregiver groups) * Complete pre- and post-intervention assessments on child EF, caregiver strain, and satisfaction * Participate in a focus group to share feedback on the intervention

What is being tested

Sponsor: University of Colorado, Denver · Participants: 40 · Started: Jul 15, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07084324

Locations in the U.S.

ColoradoUniversity of Colorado Anschutz School of Medicine, Aurora

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.